Product Information
TEMOZOLOMIDE 250 MG CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $20.5332 per EA under NDC 47335089374. Its NADAC has been published 57 times since Jul 23, 2025.
FDA first approved this application on Feb 12, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Temozolomide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
250 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
47335089374
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
10/22/2025
Active Ingredients
TEMOZOLOMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA201742FDA Approved
2/12/2014
TE Code
AB
On Market Since
2/13/2014
Pharmacological Classes
Price Statistics
The NADAC for TEMOZOLOMIDE 250 MG CAPSULE has been published 57 times since Jul 23, 2025, and over the history we have for it it has declined 11.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $20.5332 per EA |
|---|---|
| All-time high | $23.2652 (Aug 13, 2025) |
| All-time low | $20.5332 (Oct 22, 2025) |
| 52-week high | $21.8992 |
| 52-week low | $20.5332 |
| Median price | $20.5332 |
| Average price | $20.9406 |
| Largest weekly change | -6.2% (Oct 22, 2025) |
| Weeks tracked | 57 |
| Tracking since | Jul 23, 2025 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TEMOZOLOMIDE 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMOZOLOMIDE 250 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $20.5332 per EA (NDC 47335089374), effective Aug 19, 2026.
How has the price of TEMOZOLOMIDE 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMOZOLOMIDE 250 MG CAPSULE has declined 11.7%. It has been tracked across 57 weekly CMS publications since Jul 23, 2025.
What are the highest and lowest recorded NADAC prices for TEMOZOLOMIDE 250 MG CAPSULE?
Since Jul 23, 2025, the NADAC for TEMOZOLOMIDE 250 MG CAPSULE has ranged from a low of $20.5332 (Oct 22, 2025) to a high of $23.2652 (Aug 13, 2025), with a median of $20.5332 per EA.
Are there cheaper alternatives to TEMOZOLOMIDE 250 MG CAPSULE?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TEMOZOLOMIDE 250 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TEMOZOLOMIDE 250 MG CAPSULE?
TEMOZOLOMIDE 250 MG CAPSULE (NDC 47335089374) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.